Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Cholangiocarcinoma × Radiofrequency Ablation × Clear all

Phase

Phase NA 8 Phase 2 2 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Adrenal Gland Neoplasms 1

Interventions

Gemcitabine 4 Cisplatin 4 pembrolizumab 2 Photochemotherapy 2 futibatinib 1 Taxes 1 Radiofrequency Ablation 1 Paclitaxel 1 Neoadjuvant Therapy 1 Lasers 1 Fulvestrant 1 Drug Therapy 1 Capecitabine 1 Albumin-Bound Paclitaxel 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02482454 2017-08-01

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

The First People's Hospital of Changzhou

Phase 2/3 Active not recruiting

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡